Bioxcel Therapeutics

BTAI

BTAI Bioxcel Therapeutics NASDAQ
Add to watchlist
--
At close :
--
  • Post market
  • Summary
    Financials
    News
    Filings
    Profile
    BTAI Chart
    See on advanced chart >

    About

    BioXcel Therapeutics, Inc. was incorporated as a Delaware corporation on March 29, 2017 as a wholly-owned subsidiary of BioXcel. BioXcel Therapeutics, Inc., or BTI, is a clinical stage biopharmaceutical company focused on drug development that utilizes novel...
    • Highlight
      A commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      03/08/2018
    • Established Date
      03/29/2017
    • Full-time Employees
      183
    • Address
      555 Long Wharf Drive New Haven CT 06511
    • Tel
      1-475-2386837
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock
    cache time: 2024-02-21 13:20:57